1. Home
  2. GSK
  3. GSK News

Latest GSK plc (Each representing two) (GSK) News on January 22, 2025

Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?
GSK

Insider Monkey

a day ago

Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
GSK

TipRanks

3 days ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
GSK

Yahoo Finance

4 days ago

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

Is GSK plc (GSK) One of the Cheapest Stocks with Biggest Upside Potential?
GSK

Insider Monkey

5 days ago

Is GSK plc (GSK) One of the Cheapest Stocks with Biggest Upside Potential?

Healthcare M&A poised for a rebound in 2025
GSK

Yahoo Finance Video

8 days ago

Healthcare M&A poised for a rebound in 2025

GSK CEO on US Expansion, M&A, Drug Pipeline, Trump
GSK

Bloomberg

8 days ago

GSK CEO on US Expansion, M&A, Drug Pipeline, Trump

Moderna cuts sales forecast on weaker vaccine demand
GSK

Yahoo Finance

8 days ago

Moderna cuts sales forecast on weaker vaccine demand

GSK Enters Agreement to Acquire IDRx, Inc.
GSK

Business Wire

9 days ago

GSK Enters Agreement to Acquire IDRx, Inc.

Why Is GSK plc (NYSE:GSK) Among the Best FTSE Dividend Stocks to Buy Now?
GSK

Insider Monkey

15 days ago

Why Is GSK plc (NYSE:GSK) Among the Best FTSE Dividend Stocks to Buy Now?

GSK’s Nucala Gains Approval in China for CRSwNP
GSK

TipRanks

18 days ago

GSK’s Nucala Gains Approval in China for CRSwNP

GSK's Sinus Disease Drug Secures Approval In China
GSK

Benzinga

18 days ago

GSK's Sinus Disease Drug Secures Approval In China

Can GSK plc (LON:GSK) Maintain Its Strong Returns?
GSK

Simply Wall St.

23 days ago

Can GSK plc (LON:GSK) Maintain Its Strong Returns?

GSK announces CHMP of the EMA recommended expanding approval of Jemperli
GSK

TipRanks

a month ago

GSK announces CHMP of the EMA recommended expanding approval of Jemperli

GSK announces FDA granted BTD for Jemperli
GSK

TipRanks

a month ago

GSK announces FDA granted BTD for Jemperli

GSK’s lung cancer therapy gains EMA PRIME designation
GSK

Pharmaceutical Technology

a month ago

GSK’s lung cancer therapy gains EMA PRIME designation

GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex
GSK

Benzinga

a month ago

GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex

Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse
GSK

Business Wire

a month ago

Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse

GSK (LON:GSK) investors are sitting on a loss of 3.4% if they invested five years ago
GSK

Simply Wall St.

2 months ago

GSK (LON:GSK) investors are sitting on a loss of 3.4% if they invested five years ago

GSK

Morningstar Research

2 months ago

Analyst Report: GSK plc

GSK gains approval in Japan for extended indication of RSV vaccine
GSK

Pharmaceutical Technology

2 months ago

GSK gains approval in Japan for extended indication of RSV vaccine

GSK announces Japan’s MHLW approved application to extend indication of Arexvy
GSK

TipRanks

2 months ago

GSK announces Japan’s MHLW approved application to extend indication of Arexvy

GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
GSK

Benzinga

2 months ago

GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients

Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
GSK

GlobeNewswire

2 months ago

Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

GSK

Morningstar Research

2 months ago

Analyst Report: GSK plc

How analysts are reacting to RFK Jr. as Trump's HHS pick
GSK

Yahoo Finance Video

2 months ago

How analysts are reacting to RFK Jr. as Trump's HHS pick

Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick
GSK

Yahoo Finance Video

2 months ago

Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick

Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.
GSK

Yahoo Finance

2 months ago

Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too
GSK

The Wall Street Journal

2 months ago

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too

Trump’s RFK Jr. Pick Weighs on Vaccine Makers
GSK

The Wall Street Journal

2 months ago

Trump’s RFK Jr. Pick Weighs on Vaccine Makers

Stocks to Watch Friday: Alibaba, Domino's, Palantir, Ulta Beauty
GSK

The Wall Street Journal

2 months ago

Stocks to Watch Friday: Alibaba, Domino's, Palantir, Ulta Beauty

RFK Jr. News Hits Global Pharma Stocks
GSK

The Wall Street Journal

2 months ago

RFK Jr. News Hits Global Pharma Stocks

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department
GSK

The Wall Street Journal

2 months ago

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department

Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official
GSK

Yahoo Finance

2 months ago

Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official

Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official
GSK

Yahoo Finance

2 months ago

Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official

GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
GSK

Benzinga

2 months ago

GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why

Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
GSK

Benzinga

2 months ago

Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease

Health Canada approves GSK’s Ojjaara for myelofibrosis in anaemia patients
GSK

Pharmaceutical Technology

2 months ago

Health Canada approves GSK’s Ojjaara for myelofibrosis in anaemia patients

GSK

Argus Research

2 months ago

Analyst Report: GSK PLC

GSK

Argus Research

2 months ago

Market Update: GSK, HIG, HLF, MSI, AXON

AstraZeneca’s China-Fueled Plunge May Be Difficult to Shake Off
GSK

Bloomberg

2 months ago

AstraZeneca’s China-Fueled Plunge May Be Difficult to Shake Off

Moderna Slashes Hefty Premarket Gain With A Beat That's 'Not A Beat'
GSK

Investor's Business Daily

2 months ago

Moderna Slashes Hefty Premarket Gain With A Beat That's 'Not A Beat'

Moderna Surges After Crushing Sales Forecasts, Reiterating Its Outlook
GSK

Investor's Business Daily

2 months ago

Moderna Surges After Crushing Sales Forecasts, Reiterating Its Outlook

GSK’s RSV vaccine approved in Canada for adults aged 50 to 59
GSK

Pharmaceutical Technology

3 months ago

GSK’s RSV vaccine approved in Canada for adults aged 50 to 59

We Think You Can Look Beyond GSK's (LON:GSK) Lackluster Earnings
GSK

Simply Wall St.

3 months ago

We Think You Can Look Beyond GSK's (LON:GSK) Lackluster Earnings

GSK Third Quarter 2024 Earnings: EPS Misses Expectations
GSK

Simply Wall St.

3 months ago

GSK Third Quarter 2024 Earnings: EPS Misses Expectations

AstraZeneca Probe in China Adds to Concerns for Foreign Businesses
GSK

The Wall Street Journal

3 months ago

AstraZeneca Probe in China Adds to Concerns for Foreign Businesses

GSK PLC (GSK) Q3 2024 Earnings Call Highlights: Strong Specialty Medicines Growth Amid Vaccine ...
GSK

GuruFocus.com

3 months ago

GSK PLC (GSK) Q3 2024 Earnings Call Highlights: Strong Specialty Medicines Growth Amid Vaccine ...

GSK

Morningstar Research

3 months ago

Analyst Report: GSK plc

GSK Plummets To 10-Month Low As RSV, Shingles Vaccines Hit The Skids
GSK

Investor's Business Daily

3 months ago

GSK Plummets To 10-Month Low As RSV, Shingles Vaccines Hit The Skids

GSK (GSK) Q3 Earnings Surpass Estimates
GSK

Zacks

3 months ago

GSK (GSK) Q3 Earnings Surpass Estimates

GSK Stock Crumbles As Vaccine Sales Plummet And Miss Expectations
GSK

Investor's Business Daily

3 months ago

GSK Stock Crumbles As Vaccine Sales Plummet And Miss Expectations

GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024
GSK

Benzinga

3 months ago

GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024

GSK to acquire CMG1A46 from Chimagen Biosciences
GSK

TipRanks

3 months ago

GSK to acquire CMG1A46 from Chimagen Biosciences

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness
GSK

The Wall Street Journal

3 months ago

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness

GSK to acquire Chimagen’s CMG1A46 for autoimmune disease
GSK

Pharmaceutical Technology

3 months ago

GSK to acquire Chimagen’s CMG1A46 for autoimmune disease

GSK

GuruFocus.com

3 months ago

GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q2 2024 Earnings Call Highlights: Revenue ...

Carmakers’ Malaise, UBS’s Next Step: EMEA Earnings Week Ahead
GSK

Bloomberg

3 months ago

Carmakers’ Malaise, UBS’s Next Step: EMEA Earnings Week Ahead

Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
GSK

Benzinga

3 months ago

Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population

New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease
GSK

Business Wire

3 months ago

New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease

FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
GSK

Benzinga

3 months ago

FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for
GSK

Zacks

3 months ago

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
GSK

Investor's Business Daily

3 months ago

Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.

GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In New Class In Over 20 Years
GSK

Benzinga

3 months ago

GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In New Class In Over 20 Years

GSK sues Moderna for US patent infringement over COVID, RSV vaccines
GSK

Reuters

3 months ago

GSK sues Moderna for US patent infringement over COVID, RSV vaccines

Stocks to Watch Monday: Boeing, SoFi, Sirius XM, MicroStrategy
GSK

The Wall Street Journal

3 months ago

Stocks to Watch Monday: Boeing, SoFi, Sirius XM, MicroStrategy

GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year
GSK

Benzinga

3 months ago

GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year

Jim Cramer Says GSK plc (GSK) ‘Goes Higher’
GSK

Insider Monkey

3 months ago

Jim Cramer Says GSK plc (GSK) ‘Goes Higher’

GSK

Morningstar Research

3 months ago

Analyst Report: GSK plc

GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement
GSK

The Wall Street Journal

3 months ago

GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement

GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
GSK

Bloomberg

3 months ago

GSK Rises After Settling Zantac Cases for Up to $2.2 Billion

Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday
GSK

Motley Fool

3 months ago

Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday

GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits
GSK

The Wall Street Journal

3 months ago

GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits

GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement Deal, Stock Surges
GSK

Benzinga

3 months ago

GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement Deal, Stock Surges

US Venture Capital Opens Path to Funding for China Biotech Firms
GSK

Bloomberg

3 months ago

US Venture Capital Opens Path to Funding for China Biotech Firms

GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons
GSK

Business Wire

3 months ago

GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons

Why Pfizer Will Find It Hard to Appease Its Activist Investor
GSK

The Wall Street Journal

3 months ago

Why Pfizer Will Find It Hard to Appease Its Activist Investor

Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
GSK

Benzinga

3 months ago

Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated

Starboard Value takes $1 billion stake in Pfizer: Reports
GSK

Yahoo Finance

3 months ago

Starboard Value takes $1 billion stake in Pfizer: Reports

Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
GSK

Yahoo Finance

3 months ago

Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies

Millions urged to delete data from mail-order DNA test maker
GSK

The Telegraph

3 months ago

Millions urged to delete data from mail-order DNA test maker

GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
GSK

Benzinga

4 months ago

GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report

Sanofi, GSK, CSL Tapped to Expand US Bird Flu Vaccine Supply
GSK

Bloomberg

4 months ago

Sanofi, GSK, CSL Tapped to Expand US Bird Flu Vaccine Supply

GSK plc (NYSE:GSK) Doesn’t Rank Too High In The List Of The Best Global Stocks To Buy
GSK

Insider Monkey

4 months ago

GSK plc (NYSE:GSK) Doesn’t Rank Too High In The List Of The Best Global Stocks To Buy

Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
GSK

GlobeNewswire

4 months ago

Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)

GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK

Benzinga

4 months ago

GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults

GSK (LSE:GSK) Poised for Growth with Strong Sales, Strategic Alliances, and New Vaccine Launches
GSK

Simply Wall St.

4 months ago

GSK (LSE:GSK) Poised for Growth with Strong Sales, Strategic Alliances, and New Vaccine Launches

GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX
GSK

Business Wire

4 months ago

GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX

Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk
GSK

PR Newswire

4 months ago

Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk

BioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar?
GSK

Zacks

4 months ago

BioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar?

Gilead Stock Rises on Positive Study Results for Twice-Yearly HIV Drug
GSK

The Wall Street Journal

4 months ago

Gilead Stock Rises on Positive Study Results for Twice-Yearly HIV Drug

Buyout Firm GTCR Is in Advanced Talks to Acquire German Drugmaker Stada
GSK

Bloomberg

4 months ago

Buyout Firm GTCR Is in Advanced Talks to Acquire German Drugmaker Stada

GSK

Argus Research

5 months ago

Weekly Stock List

With 86% institutional ownership, GSK plc (LON:GSK) is a favorite amongst the big guns
GSK

Simply Wall St.

5 months ago

With 86% institutional ownership, GSK plc (LON:GSK) is a favorite amongst the big guns

Why Is Glaxo (GSK) Up 10.3% Since Last Earnings Report?
GSK

Zacks

5 months ago

Why Is Glaxo (GSK) Up 10.3% Since Last Earnings Report?

GSK plc (GSK): A Cheap Pharmaceutical Stock to Buy According to Short Sellers
GSK

Insider Monkey

5 months ago

GSK plc (GSK): A Cheap Pharmaceutical Stock to Buy According to Short Sellers

GSK

Investing.com

5 months ago

GSK shares rise on Delaware Supreme Court appeal in Zantac case

GSK

Argus Research

5 months ago

Daily Spotlight: Diverse Options Among Global Sovereign Debt

GSK plc (GSK): Why Are Hedge Funds Bullish on This Undervalued UK Stock Now?
GSK

Insider Monkey

5 months ago

GSK plc (GSK): Why Are Hedge Funds Bullish on This Undervalued UK Stock Now?

GSK

Argus Research

5 months ago

Analyst Report: GSK PLC

GSK

Argus Research

5 months ago

Market Digest: ACM, FSLR, GSK, MCHP, CTVA, GEHC, PLTR

Share on Social Networks: